Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street futures fall as oil, Treasury yields rise on Iran tensions
- Oil prices fall after hitting over one-month high; traders weigh supply risks
- Dell again lifts annual forecasts as AI demand powers record results
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- Berkshire’s Abel says data centers are energy opportunity
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 6c
November 3, 2022 4:18 PM EDTAdaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.32), $0.06 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $47.8 million versus the consensus estimate of $49.05 million.
GUIDANCE:
Adaptive Biotechnologies sees FY2022 revenue of $185-190 million, versus the consensus of... More
